← Leaderboards
Akshaya Kumar Meher
University Of Virginia
$1,510,000
Attributed
$1,510,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $403.8K · FY2019–22$500K$375K$250K$125K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,510,000 · 1
By mechanism
R01$1,510,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia
Same institution · by research overlap
- Loren D Erickson$7,080,830
- Thomas A. Platts-Mills$20,464,070
- Hui Zong$7,210,772
- Richard Baylis$144,471
- Bowen Wang$1,625,788
Others in their field
Other Emerging Leaders on “Cell Type”
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Thomas Denny · Duke University$19,381,749
- Tomasz Nowakowski · University Of California, San Francisco$18,472,946
- Hemali Phatnani · New York University School Of Medicine$18,358,586
- Rui M. Costa · Columbia University Health Sciences$13,762,381
Research focus
Cell TypeAgedAbdominal AortaAntibodiesAntibody TherapyAortaAneurysmAbdominal Aortic AneurysmAttenuatedBaseB-Cell ActivationB Cell DifferentiationBelimumabBindingBiochemicalAortitisAtherosclerosisBiophysical TechniquesBlood VesselsB-LymphocytesCause Of DeathCell PhysiologyCellsCoculture Techniques
Grant awards (4)
BAFF 60mer as a novel therapeutic target for vascular diseases$368,750
R01 · FY2022 · HL · contact PI
BAFF 60mer as a novel therapeutic target for vascular diseases$368,750
R01 · FY2021 · HL · contact PI
BAFF 60mer as a novel therapeutic target for vascular diseases$368,750
R01 · FY2020 · HL · contact PI
BAFF 60mer as a novel therapeutic target for vascular diseases$403,750
R01 · FY2019 · HL · contact PI